Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 2452035)

Published in Circulation on May 01, 1988

Authors

J R McEwan1, N Benjamin, S Larkin, R W Fuller, C T Dollery, I MacIntyre

Author Affiliations

1: Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, United Kingdom.

Articles citing this

Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Br J Clin Pharmacol (1994) 1.10

Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. Hypertension (2014) 0.96

Clinical pharmacology, physiology and pathophysiology of superficial veins--2. Br J Clin Pharmacol (1994) 0.96

Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J Physiol (2000) 0.90

The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. Am J Pathol (1990) 0.87

Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man. Br J Clin Pharmacol (1999) 0.86

Facilitating laser Doppler measurements of cutaneous adrenergic vasoconstriction: a comparison of methods. Clin Auton Res (2001) 0.85

Cutaneous blood flow responses in the forearms of Raynaud's patients induced by local cooling and intradermal injections of CGRP and histamine. Br J Clin Pharmacol (1990) 0.83

Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br J Clin Pharmacol (2005) 0.80

The effect of local converting enzyme inhibition on the dilator response to substance P in the human forearm. Br J Clin Pharmacol (1990) 0.78

Splanchnic and cerebral vasodilatory effects of calcitonin gene-related peptide I in humans. Ann Surg (1991) 0.75

Articles by these authors

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet (1997) 9.18

Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13

Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11

Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65

Monitoring adverse reactions to drugs. Br Med J (1977) 4.41

Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71

Stomach NO synthesis. Nature (1994) 3.70

A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51

Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33

Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25

Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13

Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63

Effect of propranolol in mild hypertension. Lancet (1966) 2.57

Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50

Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49

The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48

Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48

Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med (1994) 2.48

Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46

European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46

Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44

Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37

Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36

Clinical medicine and research in France. Br Med J (1973) 2.32

Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27

Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24

Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23

Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22

Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22

Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15

Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet (1990) 2.14

Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13

Capsaicin inhalation in man and the effects of sodium cromoglycate. Br J Pharmacol (1984) 2.12

The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06

The pharmacologic profile of fluoxetine. J Clin Psychiatry (1985) 2.04

Isolation and characterization of human calcitonin gene-related peptide. Nature (1984) 2.03

Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01

I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99

Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med (1994) 1.99

Sensitivity of the cough reflex in patients with chronic cough. Eur Respir J (1992) 1.97

Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97

Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93

Basal nitric oxide synthesis in essential hypertension. Lancet (1997) 1.92

Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92

Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91

The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem (1992) 1.89

Effects of sildenafil citrate on human hemodynamics. Am J Cardiol (1999) 1.86

Enalapril-induced cough. Lancet (1986) 1.86

Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol (1992) 1.85

Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85

Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83

Helicobacter pylori is killed by nitrite under acidic conditions. Gut (1998) 1.82

Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79

Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78

Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78

Minoxidil in resistant hypertension. Lancet (1977) 1.77

The drug treatment of hypertension. Practitioner (1971) 1.75

Epilepsy and employment. Community Health (Bristol) (1976) 1.75

Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis (1989) 1.75

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis (1993) 1.74

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73

Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci (1997) 1.72

Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72

Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70

Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68

Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68

Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol (1963) 1.67

Effect of thyrocalcitonin in man. Lancet (1966) 1.67

Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66

Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett (1985) 1.66

Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65

Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65

Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. J Clin Psychiatry (1986) 1.65

Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61

Bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol (1985) (1985) 1.61

Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci (Lond) (1991) 1.60

Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57

Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56

Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56

Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol (1995) 1.56

Retracted Altered calcitonin gene in a young patient with osteoporosis. BMJ (1989) 1.55

A biological assay for calcitonin. J Endocrinol (1965) 1.53

Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52

Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52

Plasma nitrate concentrations in children with infectious and noninfectious diarrhea. J Pediatr Gastroenterol Nutr (2001) 1.51

Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50

Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49

Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48

Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet (1981) 1.47

Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut (1997) 1.46

Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46

Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46

Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46